Redeye provides its initial take on Vitec’s Q2 2025 report, which came in considerably below our est...
Redeye comments on Lime’s Q2 report, showing solid underlying numbers despite sales being hurt by so...
Redeye updates its production estimates ahead of Arise's Q2 report on Friday next week (18 July).
Redeye updates its Base Case and forecasts following the Q2 report, showing solid underlying busines...
- Earnings naturally hedged - Potential to generate order intake above the historical average - NTM ...
- '25e-'27e adj. EBITA down 5-3% - Weaker UK retail sales could impede EBITA growth - '25e EV/adj.
Beijer Alma har genomfört fyra förvärv i år, varav ett under det andra kvartalet.
Redeye is growing more optimistic about the investment case in Oncopeptides after two news items thi...
Finnair reports Q2 results on Jul 16. Industrial action has continued to affect performance, while t...
Redeye comments on Modelons’ proposed directed share issue of SEK20m at SEK20 per share, representin...
Redeye comments on Invisio ahead of Q2-results (due 18 July) where we expect sequential improvement ...
Redeye lifts its ARR and EBITDA-CAPEX estimates for Litium after the Q2 report, where ARR growth sig...
- Report out 18 July - Q2e: sales SEK 37m, -3% y-o-y, EBIT SEK -0.
Redeye positively views yesterday’s press release from Acarix announcing that it has secured its fir...
Coor förväntas redovisa en något lägre omsättning, men förbättrade marginaler tack vare lägre person...
